Luvox and Poor venous access - a phase IV clinical study of FDA data

Summary:

Poor venous access is reported as a side effect among people who take Luvox (fluvoxamine maleate), especially for people who are female, 60+ old, also take Metformin, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Poor venous access when taking Luvox. It is created by eHealthMe based on reports of 12,486 people who have side effects when taking Luvox from the FDA, and is updated regularly.

What is Luvox?

Luvox has active ingredients of fluvoxamine maleate. It is often used in obsessive-compulsive disorder. eHealthMe is studying from 13,439 Luvox users. Check the latest studies of Luvox.

What is Poor venous access?

Poor venous access is found to be associated with 674 drugs and 479 conditions by eHealthMe. Check the latest studies of Poor venous access.

On Jul, 15, 2026

12,486 people reported to have side effects when taking Luvox.
Among them, 12 people (0.1%) have Poor venous access.

Among these 12 people:

What is the gender of people who have Poor venous access when taking Luvox? *

female: 100 %
male: 0.0 %

What is the age of people who have Poor venous access when taking Luvox? *

What are other drugs people take besides Luvox? *

What are other side effects people have besides Poor venous access? *

Pain: 8 people, 66.67%
Joint Swelling: 6 people, 50.00%
Staphylococcal Infection (an infection with staphylococcus bacteria): 6 people, 50.00%
Joint Pain: 6 people, 50.00%
Hypotension (abnormally low blood pressure): 6 people, 50.00%
Nasopharyngitis (inflammation of the nasopharynx): 6 people, 50.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 6 people, 50.00%
Femur Fracture: 6 people, 50.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 50.00%
Fall: 6 people, 50.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 58.33%
Hepatitis (inflammation of the liver): 6 people, 50.00%
Diabetes: 6 people, 50.00%
Immunodeficiency Common Variable: 4 people, 33.33%
Uveitis (inflammation of the uvea): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Luvox and have Poor venous access?

- Check whether Poor venous access is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Luvox:

Luvox (13,439 reports)

Browse all side effects of Luvox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Poor venous access:

Poor venous access (674 drugs)

Browse all the conditions that are associated with Poor venous access:

Poor venous access (479 conditions)

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on fluvoxamine maleate (the active ingredients of Luvox) and Luvox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.